MICROBE 0 - Microbiotics In Recurrent Clostridium difficile infection: Restoration Of Bacteria: An Investigator-Initiated Open Label Study to Evaluate the Tolerability Safety and Efficacy of FIN-403 in the Prevention of Recurrent CDI
M
Monika Fischer, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Not Recruiting
100 years or below
All
Phase
N/A
1 Location
Brief description of study
The purpose of this study is to evaluate the short-term safety of FIN-403 in patients with recurrent Clostridium difficile infection (CDI); to evaluate how well FIN-403 works in patients with recurrent CDI; to evaluate time to CDI recurrence after taking FIN-403; and to assess the impact of FIN-403 on quality of life.
Detailed description of study
The purpose of this study is to evaluate the short-term safety of FIN-403 in patients with recurrent Clostridium difficile infection (CDI); to evaluate how well FIN-403 works in patients with recurrent CDI; to evaluate time to CDI recurrence after taking FIN-403; and to assess the impact of FIN-403 on quality of life.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Clostridium difficile infection
-
Age: 100 years or below
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 1707399087
